Medical News

RSS

PDL BioPharma reports revenue guidance of $86 million for 2010 third quarter

PDL BioPharma, Inc. today announced revenue guidance for the third quarter ended September 30, 2010 of approximately $86 million, as compared with actual results of $71.4 million for the third quarter of 2009, a 20 percent year-over-year increase.

2 Sep 2010

Martek Biosciences 2010 third quarter revenue increases 51% to $117.2 million

Martek Biosciences Corporation today announced its financial results for the third quarter of fiscal 2010.

2 Sep 2010

Accuray Incorporated 2010 fourth quarter revenue increases to $61.8 million

Accuray Incorporated, a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2010, ended June 30, 2010.

2 Sep 2010

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

1 Sep 2010

Overflowing petitions to save local GP from deregistration

General Practitioner Dr Rajendra Moodley has helped hundreds of people in his care during his tenure. After being deregistered by the Medical Board of Australia last Friday, his patients are rising to appeal the deregistration decision.

1 Sep 2010

Doctor depression on the rise: Review

According to a review of Australian and international research released by Beyondblue this week, doctors use more prescription drugs and have a higher rate of suicide than the general population. General Practitioner Naomi Harris says doctors are less inclined to seek help for their own mental illness, resulting in some disturbing trends and she is urging doctors to come out for help being a member of an advisory committee formed to deal with the problem.

1 Sep 2010

Event Pulse report reveals impact of new therapies on MS drug market

The study titled Event Pulse Preview: Multiple Sclerosis shows that 84% of neurologists expect to prescribe Gilenia for some MS patients if approved, but prescribing will likely be limited to second- or third-line therapy until concerns about safety and monitoring requirements are resolved.

1 Sep 2010

World Bank calls for more integrated approach to global water management

"We can't properly tackle global priorities of food security, renewable energy, adaptation to climate change, public health and urbanization unless we manage water better," Julia Bucknall, water sector manager for the World Bank, said, according to a World Bank press release.

1 Sep 2010

Report finds some donated malaria drugs are being stolen, resold In Africa

Some of the malaria drugs given to Africa by international donors are "being stolen and resold on commercial markets," according to a study to be released Thursday in the journal Research and Reports in Tropical Medicine, the Associated Press reports.

1 Sep 2010

Federal domestic spending increased a record 16%

The Census Bureau reported Thursday that federal "domestic spending increased a record 16 percent, to $3.2 trillion, in 2009 … largely because of a boost in aid to the unemployed and the huge economic stimulus package enacted to rescue the sinking economy," The Washington Post reports.

1 Sep 2010

Unpleasant short term side-effects of sunburn dont put off sun-seeking Brits

The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.

31 Aug 2010

Tooth brush in a teenager’s stomach

A 15-year-old girl in New Zealand came to the emergency department at an Auckland hospital after accidentally swallowing her 19-centimetre toothbrush. The case study was published in the New Zealand Medical Journal.

31 Aug 2010

Parkinson’s disease discoveries

Genes that affect the immune system and link it to Parkinson’s disease have been uncovered. This paves the way for new drug development in Parkinson’s disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.

31 Aug 2010

Anti-smoking measures beefed up

Tasmanians are looking at one of the tightest tobacco control measures ever adopted. The Tasmanian Government is proposing a no-smoking zone at almost all public places including shopping malls and sporting venues and introducing smoke-free buffer zone around children's playgrounds.

31 Aug 2010

Sangart reports positive data from MP4OX Phase IIa study in trauma patients

Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients.

31 Aug 2010

Irving Place Capital signs agreement to acquire Alpha Packaging

Irving Place Capital, a middle-market private equity firm, announced today that it has signed a purchase agreement to acquire Alpha Packaging, a leading blow molder of plastic bottles and jars for the nutraceutical, pharmaceutical and personal care markets. IPC is investing in partnership with Alpha's current management team, led by President and Chief Executive Officer Dave Spence and Chief Operating Officer Dan Creston. The transaction is expected to close in September of 2010.

31 Aug 2010

pSivida announces FDA Priority Review status for Iluvien NDA

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has been notified that the U.S. Food and Drug Administration (FDA) has granted Priority Review status for the New Drug Application (NDA) filed for Iluvien for the treatment diabetic macular edema (DME).

31 Aug 2010

Ranaz second-quarter net earnings increase 11.5% to $410,443

Ranaz Corporation, a company specializing in the manufacturing and marketing of protein and dietary supplements, reported its results today for the second quarter ended June 30, 2010.

31 Aug 2010

Stromedix's STX-100 receives orphan drug status from FDA for treatment of IPF

Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.

31 Aug 2010